Clinical trial
A Pilot Study to Evaluate the Sensitivity of a Novel Molecular Method for Plaque Toxicity
NCT02574221 is registered in ClinicalTrials.gov with Procter and Gamble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Evaluate the Sensitivity of a Novel Molecular Method for Plaque Toxicity
- Lead sponsor
- Procter and Gamble
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2015
- Completion date
- October 31, 2015
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gingivitis, plaque